Study on explaining scleroderma research results to patients
Part of Skin clinical trials.
This trial tests different ways of sharing research results with people who have scleroderma (a condition that causes hardening of the skin and sometimes internal organs). It aims to find the best way to make study results clear and helpful for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have scleroderma, confirmed by a doctor.
- You must be 18 years old or older.
- You must be able to read and understand English or French.
- You must have internet access to fill out questionnaires online.
- You need to be part of the SPIN research study or have a doctor’s report of your scleroderma diagnosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults with systemic scleroderma (also called scleroderma) to better understand the condition over time. You may be included if you meet specific diagnosis and blood-test requirements and can give informed consent.
This study looks at what influences people with scleroderma to join clinical trials. By taking part, you help researchers understand how to make future studies more accessible and patient-friendly.
This trial collects skin samples from people with scleroderma and from healthy volunteers undergoing plastic surgery. Researchers will study the genes in skin cells to better understand the disease.
This study looks at skin cells and immune cells in people with systemic sclerosis to better understand what drives the disease. Your participation may help researchers learn how the immune system and skin support cells change over time.
This study looks at how scleroderma affects physical performance and daily function in children and adults. It aims to understand the impact of the disease on movement and everyday activities.
This study is looking at how systemic sclerosis (a disease that can cause skin thickening and organ problems) affects muscles. It may help find better ways to care for patients.
Hear when a new Scleroderma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.